Every 424B that Procter & Gamble (PG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow PG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PG filings page.
The Procter & Gamble Company is offering $258,889,000 of Floating Rate Notes due 2075 under a prospectus supplement. The notes pay interest quarterly at Compounded SOFR minus 0.45% per year, with a 0.00% floor, starting on February 4, 2026, and mature on November 4, 2075.
The notes are priced at 100.000% with a 1.000% underwriting discount, for proceeds to the company of $256,300,110 before expenses. They are expected to settle through DTC on or about November 4, 2025 and will not be listed on any exchange.
P&G may redeem the notes, in whole or in part, beginning November 4, 2055 at step-down prices from 105.00% to 100.00% by 2065 and thereafter at par. Holders may require repurchase beginning November 4, 2026 annually through 2036 at 98.00%–100.00%, and every third year thereafter at 100.00%. Upon a defined tax event, P&G may shorten the maturity to preserve U.S. interest deductibility, paying 100% of principal plus accrued interest on the new maturity date.
The Procter & Gamble Company launched a registered debt offering of $1,250,000,000, consisting of $750,000,000 4.100% notes due November 3, 2032 and $500,000,000 4.350% notes due November 3, 2035. Interest accrues from November 3, 2025 and is payable semiannually on May 3 and November 3, with the first payment on May 3, 2026. The notes are not listed on any exchange.
Initial offering prices were 99.916% (2032s) and 99.831% (2035s), with underwriting discounts of 0.400% and 0.450%, respectively. Total proceeds to the company before expenses are $1,243,275,000. The notes are optionally redeemable at a make-whole price based on the Treasury Rate +5 bps (2032s) and Treasury Rate +10 bps (2035s), or at 100% of principal, in each case plus accrued interest to, but excluding, the redemption date.
Delivery is expected through DTC, Clearstream and Euroclear on or about November 3, 2025. Recent quarterly results (three months ended September 30, 2025) show net sales of $22,386 million and net earnings attributable to P&G of $4,750 million.
The Procter & Gamble Company priced a primary offering of €1,000,000,000 senior euro notes in two tranches: €500,000,000 of 2.900% notes due November 3, 2033 and €500,000,000 of 3.650% notes due November 3, 2045. Interest accrues from November 3, 2025 and is payable annually in arrears, with the first payment on November 3, 2026.
The pricing table shows initial offering prices of 99.761% (2033) and 99.916% (2045), underwriting discounts of 0.338% and 0.500%, and aggregate proceeds to the issuer before expenses of €994,195,000. The notes are optionally redeemable at a make‑whole amount based on the applicable Comparable Government Bond Rate plus 10 bps. Application will be made to list the notes on the NYSE, subject to approval. The notes will clear through Clearstream and Euroclear and will be issued in €100,000 denominations (and €1,000 multiples thereafter).
The Procter & Gamble Company launched a preliminary prospectus supplement for a primary offering of Floating Rate Notes due 2075. The notes pay interest quarterly at a rate equal to Compounded SOFR minus 0.45%, with a 0.00% floor, beginning on February 4, 2026, and mature on November 4, 2075. The company may redeem the notes, in whole or in part, starting November 4, 2055 at step-down prices listed in the supplement, plus accrued interest. Holders have put rights beginning November 4, 2026, annually through 2036 at stated prices and every third year thereafter at 100% of principal, each plus accrued interest. If a tax event occurs, P&G may shorten maturity so interest remains deductible for U.S. federal income tax purposes. The notes will not be listed on any exchange and are expected to settle via DTC; Morgan Stanley is named in the supplement.
For context, for the quarter ended September 30, 2025, net sales were $22,386 million, operating income was $5,856 million, and net earnings attributable to P&G were $4,750 million. Diluted EPS was $1.95 on diluted weighted average shares of 2,436.8 million.
Procter & Gamble (PG) filed a preliminary prospectus supplement for a two‑tranche senior notes offering. The company plans to issue two series of notes with semiannual interest payments beginning in 2026, accruing from 2025. The notes may be redeemed at P&G’s option at a make‑whole price based on a Treasury Rate formula. The notes will be delivered through DTC, Clearstream and Euroclear and will not be listed on any exchange. Proceeds, before expenses, are payable to the company.
Underwriters include Citigroup, Goldman Sachs and Morgan Stanley. As context, for the quarter ended September 30, 2025, net sales were $22,386 million versus $21,737 million a year ago, and net earnings attributable to P&G were $4,750 million versus $3,959 million. Diluted EPS was $1.95. As of September 30, 2025, long‑term debt was $24,315 million and shareholders’ equity was $53,551 million.
The Procter & Gamble Company launched a preliminary prospectus supplement for a primary offering of euro‑denominated senior notes in two series. Interest will be paid annually in arrears starting in 2026, and the notes may be redeemed at P&G’s option at make‑whole prices, plus a tax redemption if certain U.S. tax events occur. The notes will be issued in registered form in minimum denominations of €100,000 and integral multiples of €1,000. Application will be made to list the notes on the New York Stock Exchange.
The offering will settle in book‑entry form through Clearstream and Euroclear. The supplement includes standard “additional amounts” provisions for non‑U.S. holders to address withholding, and outlines product governance and retail investor restrictions in the EEA and UK. P&G highlights macroeconomic, geopolitical, supply chain, cybersecurity and regulatory risks relevant to its global operations.
As context, for the quarter ended September 30, 2025, net sales were $22,386 million and net earnings attributable to P&G were $4,750 million, with diluted EPS of $1.95. As of September 30, 2025, total assets were $127,599 million, long‑term debt was $24,315 million and shareholders’ equity was $53,551 million.